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Introduction
Urinary tract infection (UTI) is common in children and 
is a major reason for referral to emergency rooms and for 
hospitalization.1,2 The spectrum of UTIs ranges from un-
complicated lower UTIs to frank abscess formation.3 
Children with acute pyelonephritis (APN) are prone to 
renal scarring and possible hypertension and chronic renal 
failure.4 Acute lobar nephronia (ALN), also known as acute 
focal bacterial nephritis, is an acute focal bacterial infection 
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BACKGROUND/PURPOSE: This aim of this study was to assess the clinical manifestations, the microor-
ganisms involved and their antibiotic resistance in children hospitalized due to acute lobar nephronia (ALN) 
and non-ALN community-acquired urinary tract infections (UTIs).
METHODS: We retrospectively reviewed the records of 265 previously healthy children hospitalized due 
to a first-episode of community-acquired febrile UTI between July 2004 and June 2007. Based on the re-
sults of renal ultrasonography and computed tomography, they were divided into ALN and non-ALN 
groups. Their demographic and clinical characteristics, distribution of microorganisms, and their antimi-
crobial resistance were analyzed.
RESULTS: Of the total number of cases of children admitted with a first-episode community-acquired UTI, 
19.2% (n = 51) were diagnosed as ALN. Children with ALN were older (1.86 years vs. 0.81 years; p < 0.01), had longer 
periods of fever before admission (4.7 days vs. 1.4 days; p < 0.01), higher peak body temperatures (39.5°C vs. 38.9°C; 
p < 0.01), higher white cell counts (18.86 ˜  109/L vs. 15.08 ˜  109/L; p < 0.01) and higher C-reactive protein levels 
(9.0 mg/dL vs. 3.5 mg/dL; p < 0.01) compared with non-ALN children. Fever also persisted for longer after the start 
of antibiotic treatment in the ALN children (2.7 days vs. 1.4 days: p < 0.01) and they required longer hospital stays 
and incurred higher medical costs. The major pathogen found in ALN was E. coli (90%). The E. coli isolated 
from ALN children was more resistant to cotrimoxazole and ciprofloxacin than those from non-ALN children.
CONCLUSION: ALN is not uncommon in children with a first-episode febrile UTI. They have a prolonged 
clinical course, higher inflammatory parameters, longer hospital stays and incur higher medical costs. 
E. coli is the major pathogen isolated from these children.
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of the kidney without liquefaction.5 ALN represents an 
inflammatory upper UTI that lies somewhere between 
APN and the early stages of renal abscess.6 A high inci-
dence of urinary tract anomalies is also associated with 
ALN.7 The diagnosis of ALN is often delayed due to the 
nonspecific nature of the symptoms.8 With the greater 
understanding of ALN and the use of ultrasound and 
computed tomography (CT), the condition is now diag-
nosed more frequently and more quickly in children pre-
senting with UTIs.9 Longer periods of antibiotic treatment 
are needed for ALN.10 Escherichia coli is the major pathogen 
found in the various UTIs, including ALN, and the drug 
resistance rate is increasing continuously.6,8,11
This study reviewed the cases of febrile children hospi-
talized due to a first episode of community-acquired UTI 
over a 3-year period in Northern Taiwan. We evaluated the 
demographic and clinical characteristics, laboratory ex-
aminations, imaging studies, causative microorganisms, 
and their antibiotic resistance and compared the results 
with those of uncomplicated febrile UTIs. The aims of 
this study were to find out the prevalence ALN in healthy 
children hospitalized for UTIs, and to compare ALN with 
other uncomplicated UTIs.
Methods
Case collection
This retrospective study comprised febrile children (body 
temperature > 38°C, and aged < 18 years) with a culture-
proven UTI who were hospitalized at the Department of 
Pediatrics of the National Taiwan University Hospital be-
tween July 2004 and June 2007. Using the International 
Classification of Disease, 9th revision (ICD-9), the medical 
records of children discharged from hospital with a UTI 
(code 599.0), APN (code 590.1), and pyelonephritis, un-
specified (code 590.80) were reviewed. Only healthy chil-
dren with a first UTI were enrolled. Children with evident 
renal abscess, afebrile UTIs, recurrent UTIs, any known 
urological anomalies, or underlying diseases such as onco-
logic disorders, neurologic disorders affecting urination, 
or immunodeficiency were excluded. Children who devel-
oped UTI during hospitalization (> 48 hours) or within 
48 hours of hospital discharge were also excluded. The de-
mographic characteristics, clinical manifestations and out-
comes, laboratory tests, imaging studies, culture results, 
antimicrobial susceptibilities, and medical costs involved 
were evaluated retrospectively. Patients were divided into 
two groups: one with ALN and the other with uncompli-
cated febrile UTIs (non-ALN). The aforementioned varia-
bles were compared for these two groups.
Urine culture and drug sensitivity test
A UTI was identified by urine culture if: at least one mi-
croorganism was detected in a urine specimen collected 
by suprapubic puncture; if > 104 colony-forming units 
(CFU)/mL were detected in a sample obtained by transure-
thral catheterization; or > 105 CFU/mL was detected in 
voided midstream urine or in sterile urine after urine-bag 
collection.11–13 UTI was also considered if CT findings 
suggested ALN, or there were other abnormal findings in 
the imaging studies, regardless of the results of the urine 
culture.14 The identification of microbial growth and the 
determination of antimicrobial susceptibility was per-
formed using the disk diffusion method according to the 
guidelines of the Clinical and Laboratory Standards 
Institute.15 Ertap enem was substituted for imipenem 
from September 2005 and ceftazidime for ciprofloxacin 
from March 2006 according to the laboratory protocol. 
Empiric antibiotic therapy was defined as inappropriate 
when the isolated pathogens showed in vitro resistance to 
all the antimicrobial agents used. Generally, antibiotics 
were shifted from an intravenous to an oral form 2–3 days 
after defervescence.
Imaging studies
Children admitted with a suspicious UTI underwent renal 
ultrasonography (RUS), performed by an experienced 
pediatric nephrologists, within 1–3 days of hospitaliza-
tion. CT was performed if the RUS revealed unilateral/
bilateral nephromegaly, a focal renal mass, or if the pa-
tient with borderline nephromegaly remained febrile for 
72 hours after the start of antibiotic treatment.10 A diagno-
sis of ALN was made based on positive CT findings, or the 
presence of nephromegaly with or without a focal renal 
mass.9,10 The characteristic features of ALN were not visi-
ble on the CT scans before contrast medium was injected, 
but wedge-shaped areas of decreased nephrogenic density 
were visible after the injection of contrast medium.3 
Unless the parents refused permission to perform voiding 
cystourethrography (VCUG), the technique was used to 
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detect vesicoureteral reflux (VUR) in most of the children 
after their fever subsided. This was not done in some girls 
older than 5 years of age with a first presentation of UTI.
Statistical analysis
The data were analyzed using SPSS version 15.0 (LEAD 
Technologies Inc, Illinois, Chicago, USA). Data from the 
two groups were compared using a χ2 test for categorical 
variables and the Mann-Whitney U test for continuous 
variables. A p < 0.05 was considered statistical significant.
Results
In total, 265 consecutive, healthy, febrile children with a 
first-episode community-acquired UTI were identified. 
Fifty-one children (19.2%) were diagnosed with ALN: all had 
positive findings on RUS and 40 of them had typical find-
ings on CT scans (i.e. a wedge-shaped decrease in nephro-
genic density on injection of contrast medium). The other 
214 children (80.8%) were diagnosed with uncomplicated 
UTIs.
Clinical characteristics of patients
The ages of the children at first presentation ranged from 
3 days to 14.7 years, with a median age of 0.31 years; 81.1% 
were under one year of age. The mean age of the ALN 
group (1.86 years; range, 23 days to 14.7 years) was older 
than that of the uncomplicated UTI group (0.81 years; 
range, 3 days to 10.9 years) (p < 0.01; Table 1). The percent-
age of children less than 3 months old was lower in the 
ALN group than in the uncomplicated UTI group (13.7% 
vs. 47.2%; p < 0.01). Boys predominated in each group, es-
pecially at less than 1 year of age. Children with ALN had 
longer periods of fever and higher peak body temperatures 
before admission (4.7 days vs. 1.4 days; 39.5°C vs. 38.9°C, 
respectively; p < 0.001). Children with ALN were also 
slower to reach defervescence after antibiotic treatment 
than those without ALN (2.7 days vs. 1.4 days; p < 0.001). 
The longest time needed for defervescence after antibiotic 
treatment in the ALN children was 10 days.
Most of the children in this study were too young to 
express specific subjective symptoms of UTI such as dys-
uria, frequency or frank back pain, so these data were only 
available for some children. Other symptoms, such as poor 
appetite, diarrhea, nausea and/or vomiting were recorded. 
The frequency of these symptoms, whether specific or 
nonspecific for UTI, was low and similar between the two 
groups.
Most children received empiric antibiotics comprising 
first generation cephalosporin and/or gentamicin, except 
for the young infants (< 3 months of age), who received 
ampicillin and gentamicin empirically. The rate of inap-
propriate empiric antibiotic treatment was slightly higher 
in the ALN group than in uncomplicated UTI group (9.8% vs. 
4.7%; p > 0.05). The rates of change for the antibiotics were 
33.3% and 37.9% for the ALN and uncomplicated groups, 
respectively. The reasons for changing antibiotic were: in-
appropriate antibiotic (23.5% vs. 11.1%; p > 0.05), remain-
ing febrile after antibiotic use for 2 days (29.49% vs. 1.2%; 
p < 0.001), or infection with uropathogens only suscepti-
ble to gentamicin (41.2% vs. 71.6%; p < 0.05). Other reasons 
included downgrading of the antibiotics, or concomitant 
medical conditions such as otitis media.
Children with ALN required longer periods of antibi-
otic therapy, via either intravenous or oral administration 
(19.1 days vs. 10.5 days; p < 0.05). Children with ALN also 
had longer hospital stays (8.6 days vs. 6.7days; p < 0.05) and 
higher medical costs (NT$38,927 vs. NT$30,369, p < 0.05). 
None of the children with ALN had urosepsis, compared 
with four children with uncomplicated UTIs. All four 
episodes of urosepsis were caused by E. coli. One child with 
E. coli ALN also suffered from idiopathic thrombocyto-
penic purpura and was given intravenous immunoglobulin 
therapy.
Laboratory and imaging studies
All children had blood samples taken and urine analysis on 
admission. Higher white cell counts were noted in the ALN 
group (18.86 ˜  109/L vs. 15.08 ˜  109/L; p < 0.01) as well 
higher neutrophil counts (61.4% vs. 52.7%; p < 0.01) (Table 
2). The inflammatory marker, C-reactive protein, was sig-
nificantly higher in children with ALN (9.0 mg/dL vs. 
3.5 mg/dL; p < 0.01). The incidence of pyuria was 98.0% in 
children with ALN compared with 85.5% in children with 
uncomplicated UTIs (p < 0.01). The incidence of hematu-
ria (41.2% vs. 34.6%) and positive nitrite tests (29.4% vs. 
28.5%) was similar in each group.
Of the 51 children with ALN, 20 had left-sided ALN, 
12 had right-sided ALN, and 19 had bilateral ALN. RUS 
and VCUG were performed to identify any genitourinary 
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Table 1. Comparisons of demographics and clinical manifestations between acute lobar nephronia and non-acute lobar nephronia 
childrena
Variable ALN group (n = 51) non-ALN group (n = 214) p
Age (yr) 1.86 ± 2.77 0.81 ± 1.78 < 0.001c
 Age < 1 yr 32 (62.7) 183 (85.5) < 0.001c
 Age < 3 mo 7 (13.7) 101 (47.2) < 0.001c
Sex, male 30 (58.8) 138 (64.5) 0.553
 < 1 yr, male 25 (78.1) 128 (69.9) 0.465
Fever before admission (d) 4.7 ± 6.2 1.4 ± 1.7 < 0.001c
Peak body temperature (°C) 39.5 ± 0.7 38.9 ± 0.6 < 0.001c
Symptomsb
 Dysuria  4/12 8/12 0.221
 Frequency  1/11 2/10 0.929
 Flank pain  5/11 6/10 0.819
 Poor appetite 12/51 51/214 0.891
 Diarrhea  7/51 30/214 0.865
 Nausea/vomiting  9/51 26/214 0.417
Time to defervescence (d) 2.7 ± 1.9 1.4 ± 1.2 < 0.001c
Inappropriate empiric antibiotic 5 (9.8) 10 (4.7) 0.251
Change of antibiotics 17 (33.3) 81 (37.9) 0.645
 Inappropriate antibiotics 4 (23.5) 9 (11.1) 0.297
 Still febrile 2 days after admission 5 (29.4) 1 (1.2) < 0.001c
 Susceptible to GM only 7 (41.2) 58 (71.6) 0.029c
 Others 1 (5.9) 13 (16.0) 0.490
Duration of antibiotics (d) 19.1 ± 3.4 10.5 ± 2.3 < 0.001c
 Intravenous 7.2 ± 3.4 5.1 ± 2.0 < 0.001c
 Oral 12.0 ± 4.3 5.4 ± 2.6 < 0.001c
Hospital stay (d) 8.6 ± 4.1 6.7 ± 2.3 < 0.001c
Urosepsis  0 (0)   4 (1.9) 0.730
Medical expense (NT$) 38,927 ± 20,930 30,369 ± 15,640 0.001c
aData presented as mean ± standard deviation or n (%); bdata presented as as the nominator of the positive number and the denominator of 
the number with available records; cstatistically significant. ALN = acute lobar nephronia; GM = gentamicin; NT$ = New Taiwan dollars.
tract anomalies. Forty-two children (82.3%) in the ALN 
group and 158 children (73.8%) in the uncomplicated UTI 
group were given a VCUG examination. In all, 22% per-
cent of children were found to have urologic abnormali-
ties and 17% of children given VCUG were found to have 
VUR. Eight (19.0%) of these were in the ALN group and 26 
(16.5%) were in the non-ALN group (p = 0.868). The rates of 
high-grade VUR (grade IV–V) were similar in the two groups 
(25.0% vs. 19.2%; p = 0.947). VUR was the most common 
genitourinary tract anomaly, followed by hydronephrosis 
(7%). Other anomalies included hydroureter, small kidneys, 
single kidneys, double orifice of the urethra, and Cobb’s 
collar. The rate of these genitourinary tract anomalies did 
not differ significantly between the two groups.
Uropathogens and antimicrobial resistance patterns
Two hundred and sixty-one children had a positive urine 
culture; 234 had a single pathogen, and 27 had mixed 
pathogens. Two children in each group had a negative 
culture. These four children had fever and pyuria and all 
had been pretreated with oral first generation cepha-
losporin 1–2 days prior to admission. The two children in 
 211
Comparison of acute lobar nephronia and uncomplicated urinary tract infection in children
the uncomplicated UTI group were found to have VUR on 
subsequent VCUG examination. E. coli was the most com-
mon pathogen found in both the ALN and uncomplicated 
UTI groups (90% vs. 79%; p = 0.108; Table 3). E. coli infection 
with extended-spectrum beta-lactamase (ESBL) was found 
in two of the ALN children but in none of the uncomplicated 
UTI children.
The antibiotic resistance patterns of the E. coli isolated 
from children with ALN and uncomplicated UTI are shown 
in Table 4. Overall, the E. coli strains exhibited high anti-
microbial resistance to ampicillin (77%), amoxicillin/
clavulanic acid (19%) and cotrimoxazole (45%). The E. coli 
isolates from ALN children were more resistant to cipro-
floxacin and cotrimoxazole (p < 0.01) than those from non-
ALN children. No suitable oral antibiotic could be found 
for one child with E. coli ALN after defervescence, who was 
hospitalized for 21 days on intravenous antibiotics.
Discussion
UTIs are very common in febrile children. The differential 
diagnosis of acute renal inflammatory disease can cause 
difficulties in pediatric patients, especially in young in-
fants. In 1979, Rosenfield first described ALN with the 
usual wedge-shaped distribution of inflammation com-
parable to that seen in lobar pneumonia.5 Histologically, 
ALN shows localized hyperemia, interstitial edema and 
leukocyte infiltration compared with local areas of tissue 
necrosis and liquefaction seen in renal abscess. It is not 
a rare condition and it is probably under diagnosed.10 
Therefore, with more awareness and the advancements in 
noninvasive image modalities, ALN is now being diagnosed 
with increasing frequency.7
In this study, we wanted to know the rate of ALN in 
previously healthy children hospitalized due to a first epi-
sode of community-acquired febrile UTI. Compared with 
other studies,7,16 only children without underlying disease 
were chosen for analysis, and the rate of ALN was found 
to be high (19.2%). We also found that the mean age (1.86 
years) of ALN children was significantly greater than that 
(0.81 year) of non-ALN children with uncomplicated 
UTIs. In general, febrile young infants less than 3 months 
of age are hospitalized for thorough examination. Forty-
seven percent of children in the uncomplicated UTI group 
were less than 3 months of age and were hospitalized 
within1–2 days of fever. Conversely, older children are more 
likely to be diagnosed with other febrile illnesses before ad-
mission. The specific symptoms of UTI are hard to assess 
Table 2. Comparisons of laboratory and image studies between ALN and non-ALN childrena
Variable ALN group (n = 51) non-ALN group (n = 214) p
WBC (˜109/L) 18.86 ± 8.72 15.08 ± 6.53 0.003c
Neutrophils (%) 61.4 ± 17.4 52.7 ± 15.2 < 0.001c
Hemoglobin (g/dL) 10.8 ± 1.1 11.2 ± 1.6 0.05 
Platelet count (103/μL) 321 ± 132 358 ± 121 0.143
C-reactive protein (mg/dL) 9.0 ± 6.3 3.5 ± 4.2 < 0.001c
Urinalysis
 Pyuria (WBC > 5/HPF) 50 (98.0)b 183 (85.5) 0.026c
 Hematuria (RBC > 5/HPF) 21 (41.2) 74 (34.6) 0.471
 Nitrite test 15 (29.4) 61 (28.5) 0.965
VURb 8 (19.0) 26 (16.5) 0.868
Grade I–III 6 (75.0) 21 (80.8) 0.947
Grade IV–V 2 (25.0) 5 (19.2) 0.947
Hydronephrosis 6 (11.8) 12 (5.6) 0.258
Structure anomalies 16 (31.4) 39 (18.2) 0.097
aData presented as mean ± standard deviation or n (%); bVUR was performed in 42 children in ALN group and 158 children in non-ALN group; 
cstatistically significant. ALN = acute lobar nephronia; WBC = white blood cell; RBC = red blood cell;  HPF = high power field; VUR = vesicoureteral 
reflux.
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The laboratory tests (high white cell counts, neutrophil 
counts and C-reactive protein levels) also indicated a more 
severe inflammatory process in the kidneys of these chil-
dren. This suggests that ALN is a progressive and more 
severe renal parenchyma infection.
The definitive diagnosis of ALN depends on imaging 
studies. RUS is usually the first method used and is done 
routinely in children presenting with a first UTI.14,18 ALN 
often manifests as a focal renal mass with poorly defined 
margins on RUS.18 In contrast, a renal abscess characteris-
tically presents as a central anechoic area with clearly 
defined margins7 and the sonography is normal in most 
cases of acute uncomplicated pyelonephritis.19 A CT scan 
is considered to be the most sensitive and specific imaging 
tool for ALN.3,16,20 Sonography can detect severe neph-
romegaly with a sensitivity of 90.0% and specificity of 
86.4% compared with the “gold standard” CT scan.3,16,20 
The 51 children with ALN in this study all had nephrome-
galy either with, or without, a focal renal mass as detected 
by sonography, and of the 40 who received CT scans, typi-
cal image results were found. The confirmation of ALN 
using CT scan after the finding of nephromegaly on RUS 
is helpful in practice.14
ALN is thought to be caused by an ascending infection 
from the lower urinary tract, or by hematogenous spread. 
All blood cultures were negative in the 51 ALN children. 
Table 3. Comparisons of uropathogens between acute lobar nephronia and non-acute lobar nephronia children
 ALN group (n = 51) non-ALN group (n = 214) p
Negative culture 2 (4)a 2 (1) 0.351
Positive culture 49 (96) 212 (99)
 Single pathogen 47 (96) 187 (88) 0.181
 Mixed pathogen 2 (4) 25 (12)
Pathogens
 E. coli 46 (90) 188 (79) 0.108
 ESBL-E. coli 2 (4) 0 (0) 0.048b
 Klebsiella spp. 1 (2) 21 (9) 0.164
 Proteus spp. 2 (4) 9 (4) 0.718
 Citrobacter spp. 0 (0) 3 (1) 0.962
 Enterobacter cloacae 0 (0) 1 (0.4) 0.397
 Enterococcus spp. 1 (2) 13 (6) 0.482
 Group B Streptococcus 0 (0) 2 (0.8) 0.786
 Morganella morganii 1 (2) 0 (0) 0.397
aData presented as n (%); bstatistically significant. ALN = acute lobar nephronia; ESBL = extended spectrum β-lactamase.
Table 4. Comparisons of antimicrobial resistance rate of 
E. coli between acute lobar nephronia and non-acute lobar 
nephronia childrena
 ALN group non-ALN group
 (n = 46) (n = 188) 
p
Ampicillin 82 76 0.448
Amoxicillin/ 23 18 0.622
 clavulanate
Cefazolin 20 12 0.243
Cefmetazole  2  2 0.728
Cefotaxime  7  2 0.151
Imipenem 10  0 0.237
Ertapenem  3  0 0.541
Gentamicin 22 11 0.086
Amikacin  2 0.5 0.827
Cefepime  5 0.5 0.168
Ciprofloxacin 27  6 0.009b
Ceftazidime  0  3 0.961
Levofloxacin  7  6 0.901
Cotrimoxazole 66 40 0.003b
aData presented as percentage; bstatistically significant. ALN = Acute 
lobar nephronia.
and fever is the most common symptom of UTI in in-
fants.17 Thus, diagnosis is often delayed. In our study, those 
with ALN had a history of more febrile days before admis-
sion (4.7 days) and higher peak body temperatures (39.5°C). 
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In our study, 22% of children had urologic abnormalities. 
The most frequent abnormality was VUR, affecting 17% 
of children, which is similar to that seen in a previous 
study on children with a first UTI in Taiwan.11,21 The rate 
of VUR ranges from 32% to 44% in children with ALN in 
other studies.7,8,22 The incidence rate and the severity of 
VUR were similar between the two groups in our study. 
This suggests that VUR may not be a prerequisite for 
ALN.10
E. coli was the most common pathogen causing UTIs, 
including ALN. E. coli represents over 90% of the microor-
ganisms found in ALN children in our study. The local 
guidelines in Taiwan for the antimicrobial therapy of 
UTIs in children suggest the use of first or second genera-
tion cephalosporins plus aminoglycosides, ampicillin or 
cotrimoxazole.23 The resistance of E. coli to ampicillin and 
cotrimoxazole has increased over the last decade.11 
Similarly, the E. coli in our study showed high resistance 
to ampicillin (77%) and cotrimoxazole (45%). In contrast, 
resistance to first or second generation cephalosporins or 
aminoglycosides was relative low (cefazolin, 14%; cefmeta-
zole, 2%; gentamicin, 13%). Therefore, first generation ce-
phalosporins are an appropriate treatment for pediatric 
cases of community-acquired UTIs. There were no differ-
ences in the antibiotic susceptibility of the E. coli isolated in 
this study, except to ciprofloxacin (p = 0.009) and cotrimox-
azole (p = 0.003), between the two groups. Interestingly, two 
of the children in the ALN group (4%; p < 0.05) had ESBL- 
E. coli infections. The inappropriate empiric antibiotic rates 
for ALN and non-ALN were 9.8% and 4.7%, respectively. 
The instances of antibiotic treatments were more fre-
quent than the instances of inappropriate empiric antibi-
otic treatment. The most common reason for changing 
antibiotics in the ALN group was persistent fever, after 
2 or more days of antibiotic treatment. The main reason 
for change in the uncomplicated UTI group was the isola-
tion of microbes that were only susceptible to treatment 
with gentamicin.
The clinical distinction of ALN from other renal paren-
chymal infections can be difficult, but it is extremely im-
portant because the treatment may differ. The treatment 
of ALN, such as that seen with uncomplicated febrile UTIs, 
needs only antibiotics. A 3-week treatment with antibio tics 
is recommended, rather than 10–14 days.10 In contrast, 
surgical drainage plus antibiotic treatment may be required 
for renal abscess. The early identification and prompt 
treatment of ALN is important to prevent its progression 
to renal abscess.
ALN is a more severe form of renal parenchyma infec-
tion, and the fever lasts longer in spite of effective antibi-
otic treatment.22 In this study, it took almost 3 days of 
antibiotic treatment to bring the fever down. In the same 
way, there is the need for longer periods of intravenous 
antibiotic treatment, longer hospital stays and increased 
medical costs. By understanding the natural course of 
ALN, there is no need to change antibiotics when a fever is 
sustained. It is also reasonable to separate ALN from un-
complicated UTIs, or pyelonephritis, if diagnosis related 
groups are covered by national health insurance.
In conclusion, ALN is not uncommon in previously 
healthy children with a first episode of febrile UTI, and 
should be considered as a differential diagnosis of renal 
parenchyma infection. Children with ALN usually have a 
prolonged and intractable clinical course as well as labo-
ratory data suggestive of severe inflammation. RUS should 
be done routinely and CT scan is the most sensitive diag-
nostic tool for ALN. VUR is common in children with ALN, 
but not specific for ALN. Also, longer treatments periods 
with the appropriate antibiotics is recommended for the 
therapy of ALN.
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